...
首页> 外文期刊>Therapeutic advances in cardiovascular disease. >Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review
【24h】

Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review

机译:国际指南变革后,感染性心内膜炎的流行病学:系统审查

获取原文

摘要

Introduction: All major international guidelines for the management of infective endocarditis (IE) have undergone major revisions, recommending antibiotic prophylaxis (AP) restriction to high-risk patients or foregoing AP completely. We performed a systematic review to investigate the effect of these guideline changes on the global incidence of IE. Methods: Electronic database searches were performed using Ovid Medline, EMBASE and Web of Science. Studies were included if they compared the incidence of IE prior to and following any change in international guideline recommendations. Relevant studies fulfilling the predefined search criteria were categorized according to their inclusion of either adult or pediatric patients. Incidence of IE, causative microorganisms and AP prescription rates were compared following international guideline updates. Results: Sixteen studies were included, reporting over 1.3 million cases of IE. The crude incidence of IE following guideline updates has increased globally. Adjusted incidence increased in one study after European guideline updates, while North American rates did not increase. Cases of IE with a causative pathogen identified ranged from 62% to 91%. Rates of streptococcal IE varied across adult and pediatric populations, while the relative proportion of staphylococcal IE increased (range pre-guidelines 16–24.8%, range post-guidelines 26–43%). AP prescription trends were reduced in both moderate and high-risk patients following guideline updates. Discussion: The restriction of AP to only high-risk patients has not resulted in an increase in the incidence of streptococcal IE in North American populations. The evidence of the impact of AP restriction on IE incidence is still unclear for other populations. Future population-based studies with adjusted incidence of IE, AP prescription rates and accurate pathogen identification are required to delineate findings further in these other regions.
机译:介绍:所有主要的国际感染性心内膜炎(IE)的国际准则都经历了主要的修订,推荐抗生素预防(AP)限制为高危患者或全面的AP。我们进行了系统审查,以调查这些指南对IE全球发病率的影响。方法:使用Ovid Medline,Embase和Web进行电子数据库搜索。如果他们将IE的发生率与国际准则建议的任何变更进行了比较了IE的发病率,则包括研究。符合预定搜索标准的相关研究根据其包含成人或儿科患者的含量进行分类。通过国际准则更新进行比较IE,致病微生物和AP处方率的发病率。结果:包括十六项研究,报告130万个IE案例。在全球范围内提高了IE的原始发病率。在欧洲准则更新后,调整后发病率在一项研究中增加,而北美利率没有增加。 IE鉴定的案例范围为62%至91%。链球菌的速率,即在成人和儿科群体中变化,而葡萄球菌的相对比例增加(范围预先准则16-24.8%,范围后准则26-43%)。在指南更新后,中度和高风险患者的AP处方趋势降低。讨论:将AP的限制仅为高风险患者尚未导致北美人口中的链球菌发生率增加。对IE发病率的影响影响的证据尚不清楚其他人群。未来的基于人口的研究,调整发病率,AP处方率和准确的病原体鉴定需要进一步在这些其他地区划叠调查结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号